This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Thursday's Small-Cap Winners & Losers

Leading Brands (LBIX) soared more than 26% on news that the Canada-based company's TrueBlue Blueberry Juice line will be sold by Cincinnati-based grocery-store chain Kroger. The products should hit store shelves within 30 days. Shares were rising 56 cents to $2.70.

PRG-Schultz International, (PRGX) an Atlanta-based audit-services firm, sharply narrowed its fourth-quarter losses to $2.9 million, or 43 cents a share, from last year's $175.8 million, or $28.32 a share. Revenue slipped 2.6% to $70.5 million, but this tops the only analyst's estimate of $68 million, according to Thomson Financial. Shares were gaining $1.21, or 11.9%, to $11.35.

PharmaNet Development (PDGI) said it earned $6.8 million, excluding items, or 36 cents a share in the fourth quarter, topping the 20-cent estimates sought by analysts. Last year the company, which sells clinical drug development services, posted income of $9.5 million, or 51 cents a share. Revenue, at $103.6 million, was slightly higher than last year and handily bested the $73.9 million consensus.

Looking ahead, the Princeton, N.J.-based firm expects 2007 adjusted income of $1.06 to $1.21 a share on sales of between $334 million and $339 million. Analysts are looking for $1.08 a share on $313.4 million in revenue. Shares were adding $3.05, or 15%, to $23.37.

Sun-Times Media, (SVN) which publishes The Chicago Sun-Times, among other newspapers, got a lift after announcing an unspecified foreign taxing authority had given it a "favorable review" regarding whether its international-tax liability should be adjusted as of year-end 2006. Shares were up 71 cents, or 17.8%, to $4.70.

Biosante Pharma (BPA) was higher on favorable results from a study of its Elestrin product, which treats menopausal hot flashes, published by the journal Obstetrics & Gynecology. Shares of the Lincolnshire, Ill., company were up 22 cents, or 5%, to $4.59.

Hana Biosciences (HNAB) shares climbed after an analyst with Cantor Fitzgerald upped its rating to buy from hold, citing the fact that four of Hana's drugs are on the brink of advanced-phase testing. Shares were adding 19 cents, or 5%, to $4.

TOR Minerals International (TORM) was falling after the Texas-based maker of pigments and flame retardants had a fourth-quarter loss of $275,000, or 4 cents a share, on sales of $5.4 million. Last year the company broke even on $10.1 million revenue. Shares were losing 60 cents, or 18.6%, to $2.62.

Restore Medical (REST) plummeted on lower-than-expected revenue. The company, which makes medical devices for sleep breathing disorders, said sales dropped 29% from last year to $1.1 million -- about $200,000 under two analysts' targets. Its loss widened to $4.1 million, or 26 cents a share, from $1.7 million, or $1.39 a share, a year ago, beating estimates by 2 cents. Still, shares of the St. Paul, Minn., company were falling 79 cents, or 19.2%, to $3.35.

Credit-services firm Intersections (INTX) dropped on lower fourth-quarter profits. The Chantilly, Va., company said it earned only $639,000, or 4 cents a share, compared with $4 million, or 23 cents a share, a year ago. Revenue, at $54.7 million, is 27% higher than last year and squares with Street estimates. The company said it faced $1.2 million in severence payments to former executives, and also faced a large number of credit card declines at one of its clients, hitting it for another $1.4 million. Shares were down $1.55, or 13.4%, to $10.

Drugmaker Icagen (ICGN) broadened its fourth-quarter losses by 4 cents from last year to 28 cents a share, or $6.2 million, on revenue that sank 36% to $1.3 million. Shares of the North Carolina-based company were off 29 cents, or 12.4%, to $2.05.

Pico Holdings (PICO) stumbled after announcing it will sell about 2.8 million newly minted company shares at $37 a share to institutional investors. Net proceeds are expected at bring in around $100.2 million. Shares were dropping $3.32, or 7.9%, to $38.78.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs